Mr Chad E. Davis > Dechert LLP > Boston, United States > Lawyer Profile

Dechert LLP
BOSTON, MA 02110-2605
United States
Chad E. Davis photo

Work Department

Intellectual Property


Dr. Chad E. Davis counsels companies, investors, and entrepreneurs on intellectual property matters, especially patent matters. Dr. Davis has extensive experience in prosecution and strategic development of worldwide patent portfolios, intellectual property due diligence, risk assessment through, for example, validity and infringement analyses, post-grant patent proceedings, and intellectual property contracts.

Dr. Davis represents clients in a diverse range of technologies, including pharmaceuticals, drug delivery technologies, crystal forms, organic dyes, chemical processes, polymers, proteins, antibodies, stem cell technology, medical diagnostics, medical imaging, microfluidic devices, adhesives, analytical chemistry, foams, cosmetics, and optical technologies.  For companies developing pharmaceuticals, Dr. Davis provides counsel through all aspects of the business cycle with particular acumen for developing and implementing strategies to maximize worldwide patent and regulatory exclusivities for the pharmaceutical product.


American Chemical Society; American Intellectual Property Law Association; Intellectual Property Owners Association


Ball State University, B.S., 1998, summa cum laude; University of Illinois at Urbana-Champaign, Ph.D., Chemistry, 2003; Boston College Law School, J.D., 2007

Lawyer Rankings

United States > Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)

Recommended for being ‘diligent, comprehensive, collaborative, nimble, and resourceful’, Dechert LLP‘s practice is widely recognized as a highly-competitive player in the life sciences sector, regularly acting for pharmaceutical and biotechnology companies in a wide variety of matters, including patent portfolio development for pre-public and discovery stage clients, the management of international patent portfolios, multi-million dollar transactions, and disputes brought before the USPTO. Boston’s Andrea Reid and Andrew Wilkins, who joined the firm in February 2021 from Lathrop GPM, share the helm of the practice. Chad E. Davis, also in Boston, is another name to note. Carl Morales left the firm in October 2021.